In the last 12 months, insiders at Gossamer Bio, Inc. ($GOSS) filed 244 transactions with the SEC: 12 open-market purchases totaling $1,639,614 and 10 sales totaling $79,148. Net insider sentiment: net buying.
Gossamer Bio, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Hasnain Faheem (President & CEO) — 35 transactions totaling $2,260,564
- Giraudo Bryan (COO/CFO) — 46 transactions totaling $383,955
- Milligan Sandra (Director) — 5 transactions totaling $75,229
- Christian Waage (EVP, Tech Ops and Admin) — 39 transactions totaling $54,152
- Aranda Richard (Chief Medical Officer) — 47 transactions totaling $17,246
View all SEC Filings for Gossamer Bio, Inc. (GOSS).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 19, 2026 | Christian Waage | EVP, Tech Ops and Admin | D | Stock Option (Right to Buy) | 157500 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.07% |
| March 19, 2026 | Giraudo Bryan | COO/CFO | D | Stock Option (Right to Buy) | 47667 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.02% |
| March 19, 2026 | Giraudo Bryan | COO/CFO | D | Stock Option (Right to Buy) | 96667 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.04% |
| March 19, 2026 | Giraudo Bryan | COO/CFO | A | Stock Option (Right to Buy) | 693750 | $0.00 | 693,750.0000 | 231,456,247 | 9999.99% | 0.30% |
| March 19, 2026 | Giraudo Bryan | COO/CFO | A | Stock Option (Right to Buy) | 638000 | $0.00 | 638,000.0000 | 231,456,247 | 9999.99% | 0.28% |
| March 19, 2026 | Giraudo Bryan | COO/CFO | A | Stock Option (Right to Buy) | 543750 | $0.00 | 543,750.0000 | 231,456,247 | 9999.99% | 0.23% |
| March 19, 2026 | Giraudo Bryan | COO/CFO | A | Stock Option (Right to Buy) | 181250 | $0.00 | 181,250.0000 | 231,456,247 | 9999.99% | 0.08% |
| March 19, 2026 | Giraudo Bryan | COO/CFO | A | Stock Option (Right to Buy) | 211500 | $0.00 | 211,500.0000 | 231,456,247 | 9999.99% | 0.09% |
| March 19, 2026 | Giraudo Bryan | COO/CFO | A | Stock Option (Right to Buy) | 211500 | $0.00 | 211,500.0000 | 231,456,247 | 9999.99% | 0.09% |
| March 19, 2026 | Giraudo Bryan | COO/CFO | A | Stock Option (Right to Buy) | 176667 | $0.00 | 176,667.0000 | 231,456,247 | 9999.99% | 0.08% |
| March 19, 2026 | Giraudo Bryan | COO/CFO | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 231,456,247 | 9999.99% | 0.04% |
| March 19, 2026 | Giraudo Bryan | COO/CFO | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 231,456,247 | 9999.99% | 0.03% |
| March 19, 2026 | Giraudo Bryan | COO/CFO | A | Stock Option (Right to Buy) | 47667 | $0.00 | 47,667.0000 | 231,456,247 | 9999.99% | 0.02% |
| March 19, 2026 | Giraudo Bryan | COO/CFO | A | Stock Option (Right to Buy) | 96667 | $0.00 | 96,667.0000 | 231,456,247 | 9999.99% | 0.04% |
| March 19, 2026 | Christian Waage | EVP, Tech Ops and Admin | D | Stock Option (Right to Buy) | 506250 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.22% |
| March 19, 2026 | Christian Waage | EVP, Tech Ops and Admin | D | Stock Option (Right to Buy) | 440000 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.19% |
| March 19, 2026 | Christian Waage | EVP, Tech Ops and Admin | D | Stock Option (Right to Buy) | 375000 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.16% |
| March 19, 2026 | Christian Waage | EVP, Tech Ops and Admin | D | Stock Option (Right to Buy) | 125000 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.05% |
| March 19, 2026 | Christian Waage | EVP, Tech Ops and Admin | D | Stock Option (Right to Buy) | 157500 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.07% |
| March 19, 2026 | Christian Waage | EVP, Tech Ops and Admin | A | Stock Option (Right to Buy) | 70000 | $0.00 | 70,000.0000 | 231,456,247 | 9999.99% | 0.03% |
| March 19, 2026 | Christian Waage | EVP, Tech Ops and Admin | A | Stock Option (Right to Buy) | 47667 | $0.00 | 47,667.0000 | 231,456,247 | 9999.99% | 0.02% |
| March 19, 2026 | Christian Waage | EVP, Tech Ops and Admin | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 231,456,247 | 9999.99% | 0.03% |
| March 19, 2026 | Christian Waage | EVP, Tech Ops and Admin | A | Stock Option (Right to Buy) | 126667 | $0.00 | 126,667.0000 | 231,456,247 | 9999.99% | 0.05% |
| March 19, 2026 | Christian Waage | EVP, Tech Ops and Admin | A | Stock Option (Right to Buy) | 157500 | $0.00 | 157,500.0000 | 231,456,247 | 9999.99% | 0.07% |
| March 19, 2026 | Christian Waage | EVP, Tech Ops and Admin | A | Stock Option (Right to Buy) | 157500 | $0.00 | 157,500.0000 | 231,456,247 | 9999.99% | 0.07% |
| March 19, 2026 | Christian Waage | EVP, Tech Ops and Admin | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 231,456,247 | 9999.99% | 0.05% |
| March 19, 2026 | Christian Waage | EVP, Tech Ops and Admin | A | Stock Option (Right to Buy) | 375000 | $0.00 | 375,000.0000 | 231,456,247 | 9999.99% | 0.16% |
| March 19, 2026 | Christian Waage | EVP, Tech Ops and Admin | A | Stock Option (Right to Buy) | 440000 | $0.00 | 440,000.0000 | 231,456,247 | 9999.99% | 0.19% |
| March 19, 2026 | Christian Waage | EVP, Tech Ops and Admin | A | Stock Option (Right to Buy) | 506250 | $0.00 | 506,250.0000 | 231,456,247 | 9999.99% | 0.22% |
| March 19, 2026 | Christian Waage | EVP, Tech Ops and Admin | D | Stock Option (Right to Buy) | 70000 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.03% |
| March 19, 2026 | Christian Waage | EVP, Tech Ops and Admin | D | Stock Option (Right to Buy) | 47667 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.02% |
| March 19, 2026 | Christian Waage | EVP, Tech Ops and Admin | D | Stock Option (Right to Buy) | 60000 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.03% |
| March 19, 2026 | Christian Waage | EVP, Tech Ops and Admin | D | Stock Option (Right to Buy) | 126667 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.05% |
| March 19, 2026 | Aranda Richard | Chief Medical Officer | D | Stock Option (Right to Buy) | 562500 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.24% |
| March 19, 2026 | Aranda Richard | Chief Medical Officer | D | Stock Option (Right to Buy) | 572000 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.25% |
| March 19, 2026 | Aranda Richard | Chief Medical Officer | D | Stock Option (Right to Buy) | 487500 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.21% |
| March 19, 2026 | Aranda Richard | Chief Medical Officer | D | Stock Option (Right to Buy) | 162500 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.07% |
| March 19, 2026 | Aranda Richard | Chief Medical Officer | D | Stock Option (Right to Buy) | 157500 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.07% |
| March 19, 2026 | Aranda Richard | Chief Medical Officer | D | Stock Option (Right to Buy) | 157500 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.07% |
| March 19, 2026 | Aranda Richard | Chief Medical Officer | D | Stock Option (Right to Buy) | 126667 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.05% |
| March 19, 2026 | Aranda Richard | Chief Medical Officer | D | Stock Option (Right to Buy) | 20000 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.01% |
| March 19, 2026 | Aranda Richard | Chief Medical Officer | D | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.02% |
| March 19, 2026 | Aranda Richard | Chief Medical Officer | D | Stock Option (Right to Buy) | 22784 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.01% |
| March 19, 2026 | Aranda Richard | Chief Medical Officer | D | Stock Option (Right to Buy) | 9167 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.00% |
| March 19, 2026 | Aranda Richard | Chief Medical Officer | D | Stock Option (Right to Buy) | 30000 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.01% |
| March 19, 2026 | Aranda Richard | Chief Medical Officer | A | Stock Option (Right to Buy) | 562500 | $0.00 | 562,500.0000 | 231,456,247 | 9999.99% | 0.24% |
| March 19, 2026 | Aranda Richard | Chief Medical Officer | A | Stock Option (Right to Buy) | 572000 | $0.00 | 572,000.0000 | 231,456,247 | 9999.99% | 0.25% |
| March 19, 2026 | Aranda Richard | Chief Medical Officer | A | Stock Option (Right to Buy) | 487500 | $0.00 | 487,500.0000 | 231,456,247 | 9999.99% | 0.21% |
| March 19, 2026 | Aranda Richard | Chief Medical Officer | A | Stock Option (Right to Buy) | 162500 | $0.00 | 162,500.0000 | 231,456,247 | 9999.99% | 0.07% |
| March 19, 2026 | Aranda Richard | Chief Medical Officer | A | Stock Option (Right to Buy) | 157500 | $0.00 | 157,500.0000 | 231,456,247 | 9999.99% | 0.07% |
| March 19, 2026 | Aranda Richard | Chief Medical Officer | A | Stock Option (Right to Buy) | 157500 | $0.00 | 157,500.0000 | 231,456,247 | 9999.99% | 0.07% |
| March 19, 2026 | Aranda Richard | Chief Medical Officer | A | Stock Option (Right to Buy) | 126667 | $0.00 | 126,667.0000 | 231,456,247 | 9999.99% | 0.05% |
| March 19, 2026 | Aranda Richard | Chief Medical Officer | A | Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 231,456,247 | 9999.99% | 0.01% |
| March 19, 2026 | Aranda Richard | Chief Medical Officer | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 231,456,247 | 9999.99% | 0.02% |
| March 19, 2026 | Aranda Richard | Chief Medical Officer | A | Stock Option (Right to Buy) | 22784 | $0.00 | 22,784.0000 | 231,456,247 | 9999.99% | 0.01% |
| March 19, 2026 | Aranda Richard | Chief Medical Officer | A | Stock Option (Right to Buy) | 9167 | $0.00 | 9,167.0000 | 231,456,247 | 9999.99% | 0.00% |
| March 19, 2026 | Aranda Richard | Chief Medical Officer | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 231,456,247 | 9999.99% | 0.01% |
| March 19, 2026 | Peterson Caryn | EVP, Regulatory Affairs | D | Stock Option (Right to Buy) | 506250 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.22% |
| March 19, 2026 | Peterson Caryn | EVP, Regulatory Affairs | D | Stock Option (Right to Buy) | 440000 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.19% |
| March 19, 2026 | Peterson Caryn | EVP, Regulatory Affairs | D | Stock Option (Right to Buy) | 375000 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.16% |
| March 19, 2026 | Peterson Caryn | EVP, Regulatory Affairs | D | Stock Option (Right to Buy) | 125000 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.05% |
| March 19, 2026 | Peterson Caryn | EVP, Regulatory Affairs | D | Stock Option (Right to Buy) | 157500 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.07% |
| March 19, 2026 | Peterson Caryn | EVP, Regulatory Affairs | D | Stock Option (Right to Buy) | 157500 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.07% |
| March 19, 2026 | Peterson Caryn | EVP, Regulatory Affairs | D | Stock Option (Right to Buy) | 126667 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.05% |
| March 19, 2026 | Peterson Caryn | EVP, Regulatory Affairs | D | Stock Option (Right to Buy) | 21167 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.01% |
| March 19, 2026 | Peterson Caryn | EVP, Regulatory Affairs | D | Stock Option (Right to Buy) | 18834 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.01% |
| March 19, 2026 | Peterson Caryn | EVP, Regulatory Affairs | D | Stock Option (Right to Buy) | 22784 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.01% |
| March 19, 2026 | Peterson Caryn | EVP, Regulatory Affairs | D | Stock Option (Right to Buy) | 9167 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.00% |
| March 19, 2026 | Peterson Caryn | EVP, Regulatory Affairs | D | Stock Option (Right to Buy) | 32334 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.01% |
| March 19, 2026 | Peterson Caryn | EVP, Regulatory Affairs | A | Stock Option (Right to Buy) | 506250 | $0.00 | 506,250.0000 | 231,456,247 | 9999.99% | 0.22% |
| March 19, 2026 | Peterson Caryn | EVP, Regulatory Affairs | A | Stock Option (Right to Buy) | 440000 | $0.00 | 440,000.0000 | 231,456,247 | 9999.99% | 0.19% |
| March 19, 2026 | Peterson Caryn | EVP, Regulatory Affairs | A | Stock Option (Right to Buy) | 375000 | $0.00 | 375,000.0000 | 231,456,247 | 9999.99% | 0.16% |
| March 19, 2026 | Peterson Caryn | EVP, Regulatory Affairs | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 231,456,247 | 9999.99% | 0.05% |
| March 19, 2026 | Peterson Caryn | EVP, Regulatory Affairs | A | Stock Option (Right to Buy) | 157500 | $0.00 | 157,500.0000 | 231,456,247 | 9999.99% | 0.07% |
| March 19, 2026 | Peterson Caryn | EVP, Regulatory Affairs | A | Stock Option (Right to Buy) | 157500 | $0.00 | 157,500.0000 | 231,456,247 | 9999.99% | 0.07% |
| March 19, 2026 | Peterson Caryn | EVP, Regulatory Affairs | A | Stock Option (Right to Buy) | 126667 | $0.00 | 126,667.0000 | 231,456,247 | 9999.99% | 0.05% |
| March 19, 2026 | Peterson Caryn | EVP, Regulatory Affairs | A | Stock Option (Right to Buy) | 21167 | $0.00 | 21,167.0000 | 231,456,247 | 9999.99% | 0.01% |
| March 19, 2026 | Peterson Caryn | EVP, Regulatory Affairs | A | Stock Option (Right to Buy) | 18834 | $0.00 | 18,834.0000 | 231,456,247 | 9999.99% | 0.01% |
| March 19, 2026 | Peterson Caryn | EVP, Regulatory Affairs | A | Stock Option (Right to Buy) | 22784 | $0.00 | 22,784.0000 | 231,456,247 | 9999.99% | 0.01% |
| March 19, 2026 | Peterson Caryn | EVP, Regulatory Affairs | A | Stock Option (Right to Buy) | 9167 | $0.00 | 9,167.0000 | 231,456,247 | 9999.99% | 0.00% |
| March 19, 2026 | Peterson Caryn | EVP, Regulatory Affairs | A | Stock Option (Right to Buy) | 32334 | $0.00 | 32,334.0000 | 231,456,247 | 9999.99% | 0.01% |
| March 19, 2026 | Smith Robert Paul JR | Chief Commercial Officer | D | Stock Option (Right to Buy) | 562500 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.24% |
| March 19, 2026 | Smith Robert Paul JR | Chief Commercial Officer | D | Stock Option (Right to Buy) | 572000 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.25% |
| March 19, 2026 | Smith Robert Paul JR | Chief Commercial Officer | A | Stock Option (Right to Buy) | 562500 | $0.00 | 562,500.0000 | 231,456,247 | 9999.99% | 0.24% |
| March 19, 2026 | Smith Robert Paul JR | Chief Commercial Officer | A | Stock Option (Right to Buy) | 572000 | $0.00 | 572,000.0000 | 231,456,247 | 9999.99% | 0.25% |
| March 19, 2026 | Hasnain Faheem | President & CEO | D | Stock Option (Right to Buy) | 1680000 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.73% |
| March 19, 2026 | Hasnain Faheem | President & CEO | D | Stock Option (Right to Buy) | 1540000 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.67% |
| March 19, 2026 | Hasnain Faheem | President & CEO | D | Stock Option (Right to Buy) | 1312500 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.57% |
| March 19, 2026 | Hasnain Faheem | President & CEO | D | Stock Option (Right to Buy) | 437500 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.19% |
| March 19, 2026 | Hasnain Faheem | President & CEO | D | Stock Option (Right to Buy) | 544500 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.24% |
| March 19, 2026 | Hasnain Faheem | President & CEO | D | Stock Option (Right to Buy) | 544500 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.24% |
| March 19, 2026 | Hasnain Faheem | President & CEO | D | Stock Option (Right to Buy) | 650000 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.28% |
| March 19, 2026 | Hasnain Faheem | President & CEO | D | Stock Option (Right to Buy) | 325000 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.14% |
| March 19, 2026 | Hasnain Faheem | President & CEO | D | Stock Option (Right to Buy) | 47000 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.02% |
| March 19, 2026 | Hasnain Faheem | President & CEO | D | Stock Option (Right to Buy) | 43500 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.02% |
| March 19, 2026 | Hasnain Faheem | President & CEO | A | Stock Option (Right to Buy) | 1680000 | $0.00 | 1,680,000.0000 | 231,456,247 | 9999.99% | 0.73% |
| March 19, 2026 | Hasnain Faheem | President & CEO | A | Stock Option (Right to Buy) | 1540000 | $0.00 | 1,540,000.0000 | 231,456,247 | 9999.99% | 0.67% |
| March 19, 2026 | Hasnain Faheem | President & CEO | A | Stock Option (Right to Buy) | 1312500 | $0.00 | 1,312,500.0000 | 231,456,247 | 9999.99% | 0.57% |
| March 19, 2026 | Hasnain Faheem | President & CEO | A | Stock Option (Right to Buy) | 437500 | $0.00 | 437,500.0000 | 231,456,247 | 9999.99% | 0.19% |
| March 19, 2026 | Hasnain Faheem | President & CEO | A | Stock Option (Right to Buy) | 544500 | $0.00 | 544,500.0000 | 231,456,247 | 9999.99% | 0.24% |
| March 19, 2026 | Hasnain Faheem | President & CEO | A | Stock Option (Right to Buy) | 544500 | $0.00 | 544,500.0000 | 231,456,247 | 9999.99% | 0.24% |
| March 19, 2026 | Hasnain Faheem | President & CEO | A | Stock Option (Right to Buy) | 650000 | $0.00 | 650,000.0000 | 231,456,247 | 9999.99% | 0.28% |
| March 19, 2026 | Hasnain Faheem | President & CEO | A | Stock Option (Right to Buy) | 325000 | $0.00 | 325,000.0000 | 231,456,247 | 9999.99% | 0.14% |
| March 19, 2026 | Hasnain Faheem | President & CEO | A | Stock Option (Right to Buy) | 47000 | $0.00 | 47,000.0000 | 231,456,247 | 9999.99% | 0.02% |
| March 19, 2026 | Hasnain Faheem | President & CEO | A | Stock Option (Right to Buy) | 43500 | $0.00 | 43,500.0000 | 231,456,247 | 9999.99% | 0.02% |
| March 19, 2026 | Giraudo Bryan | COO/CFO | D | Stock Option (Right to Buy) | 693750 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.30% |
| March 19, 2026 | Giraudo Bryan | COO/CFO | D | Stock Option (Right to Buy) | 638000 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.28% |
| March 19, 2026 | Giraudo Bryan | COO/CFO | D | Stock Option (Right to Buy) | 543750 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.23% |
| March 19, 2026 | Giraudo Bryan | COO/CFO | D | Stock Option (Right to Buy) | 181250 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.08% |
| March 19, 2026 | Giraudo Bryan | COO/CFO | D | Stock Option (Right to Buy) | 211500 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.09% |
| March 19, 2026 | Giraudo Bryan | COO/CFO | D | Stock Option (Right to Buy) | 211500 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.09% |
| March 19, 2026 | Giraudo Bryan | COO/CFO | D | Stock Option (Right to Buy) | 176667 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.08% |
| March 19, 2026 | Giraudo Bryan | COO/CFO | D | Stock Option (Right to Buy) | 100000 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.04% |
| March 19, 2026 | Giraudo Bryan | COO/CFO | D | Stock Option (Right to Buy) | 60000 | $0.00 | 0.0000 | 231,456,247 | 100.00% | 0.03% |
| Jan. 2, 2026 | Christian Waage | EVP, Tech Ops and Admin | A | Stock Option (Right to Buy) | 506250 | $0.00 | 506,250.0000 | 231,456,247 | 9999.99% | 0.22% |
| Jan. 2, 2026 | Christian Waage | EVP, Tech Ops and Admin | A | Common Stock | 84500 | $0.00 | 882,175.0000 | 231,456,247 | 10.59% | 0.04% |
| Jan. 2, 2026 | Peterson Caryn | EVP, Regulatory Affairs | A | Stock Option (Right to Buy) | 506250 | $0.00 | 506,250.0000 | 231,456,247 | 9999.99% | 0.22% |
| Jan. 2, 2026 | Peterson Caryn | EVP, Regulatory Affairs | A | Common Stock | 84500 | $0.00 | 259,333.0000 | 231,456,247 | 48.33% | 0.04% |
| Jan. 2, 2026 | Aranda Richard | Chief Medical Officer | A | Stock Option (Right to Buy) | 562500 | $0.00 | 562,500.0000 | 231,456,247 | 9999.99% | 0.24% |
| Jan. 2, 2026 | Aranda Richard | Chief Medical Officer | A | Common Stock | 93750 | $0.00 | 465,645.0000 | 231,456,247 | 25.21% | 0.04% |
| Jan. 2, 2026 | Smith Robert Paul JR | Chief Commercial Officer | A | Stock Option (Right to Buy) | 562500 | $0.00 | 562,500.0000 | 231,456,247 | 9999.99% | 0.24% |
| Jan. 2, 2026 | Smith Robert Paul JR | Chief Commercial Officer | A | Common Stock | 93750 | $0.00 | 285,898.0000 | 231,456,247 | 48.79% | 0.04% |
| Jan. 2, 2026 | Giraudo Bryan | COO/CFO | A | Stock Option (Right to Buy) | 693750 | $0.00 | 693,750.0000 | 231,456,247 | 9999.99% | 0.30% |
| Jan. 2, 2026 | Giraudo Bryan | COO/CFO | A | Common Stock | 115750 | $0.00 | 869,747.0000 | 231,456,247 | 15.35% | 0.05% |
| Jan. 2, 2026 | Hasnain Faheem | President & CEO | A | Stock Option (Right to Buy) | 1680000 | $0.00 | 1,680,000.0000 | 231,456,247 | 9999.99% | 0.73% |
| Jan. 2, 2026 | Hasnain Faheem | President & CEO | A | Common Stock | 280000 | $0.00 | 6,245,866.0000 | 231,456,247 | 4.69% | 0.12% |
| Oct. 1, 2025 | Peterson Caryn | EVP, Regulatory Affairs | A | Common Stock | 125000 | $0.00 | 174,833.0000 | 227,221,261 | 250.84% | 0.06% |
| Oct. 1, 2025 | Hasnain Faheem | President & CEO | A | Common Stock | 437500 | $0.00 | 5,965,866.0000 | 227,221,261 | 7.91% | 0.19% |
| Oct. 1, 2025 | Aranda Richard | Chief Medical Officer | A | Common Stock | 162500 | $0.00 | 371,895.0000 | 227,221,261 | 77.60% | 0.07% |
| Oct. 1, 2025 | Giraudo Bryan | COO/CFO | A | Common Stock | 181250 | $0.00 | 753,997.0000 | 227,221,261 | 31.65% | 0.08% |
| Oct. 1, 2025 | Christian Waage | EVP, Tech Ops and Admin | A | Common Stock | 125000 | $0.00 | 779,048.0000 | 227,221,261 | 19.11% | 0.06% |
| Oct. 1, 2025 | Smith Robert Paul JR | Chief Commercial Officer | A | Common Stock | 162500 | $0.00 | 187,500.0000 | 227,221,261 | 650.00% | 0.07% |
| Aug. 19, 2025 | Milligan Sandra | Director | P | Common Stock | 26050 | $1.92 | 58,050.0000 | 227,221,261 | 81.41% | 0.01% |
| June 25, 2025 | Daniel Thomas O | Director | A | Stock Option (Right to Buy) | 115000 | $0.00 | 115,000.0000 | 227,221,261 | 9999.99% | 0.05% |
| June 25, 2025 | Drynan Skye | Director | A | Stock Option (Right to Buy) | 115000 | $0.00 | 115,000.0000 | 227,221,261 | 9999.99% | 0.05% |
| June 25, 2025 | Milligan Sandra | Director | A | Stock Option (Right to Buy) | 115000 | $0.00 | 115,000.0000 | 227,221,261 | 9999.99% | 0.05% |
| June 25, 2025 | Quisel John D | Director | A | Stock Option (Right to Buy) | 115000 | $0.00 | 115,000.0000 | 227,221,261 | 9999.99% | 0.05% |
| June 25, 2025 | Cox Russell J. | Director | A | Stock Option (Right to Buy) | 115000 | $0.00 | 115,000.0000 | 227,221,261 | 9999.99% | 0.05% |
| June 25, 2025 | Nathan Steven D | Director | A | Stock Option (Right to Buy) | 115000 | $0.00 | 115,000.0000 | 227,221,261 | 9999.99% | 0.05% |
| March 4, 2025 | Hasnain Faheem | President & CEO | A | Stock Option (Right to Buy) | 1540000 | $0.00 | 1,540,000.0000 | 0 | 9999.99% | 0.00% |
| March 4, 2025 | Smith Robert Paul JR | Chief Commercial Officer | A | Stock Option (Right to Buy) | 572000 | $0.00 | 572,000.0000 | 0 | 9999.99% | 0.00% |
| March 4, 2025 | Peterson Caryn | EVP, Regulatory Affairs | A | Stock Option (Right to Buy) | 440000 | $0.00 | 440,000.0000 | 0 | 9999.99% | 0.00% |
| March 4, 2025 | Christian Waage | EVP, Tech Ops and Admin | A | Stock Option (Right to Buy) | 440000 | $0.00 | 440,000.0000 | 0 | 9999.99% | 0.00% |
| March 4, 2025 | Giraudo Bryan | COO/CFO | A | Stock Option (Right to Buy) | 638000 | $0.00 | 638,000.0000 | 0 | 9999.99% | 0.00% |
| March 4, 2025 | Aranda Richard | Chief Medical Officer | A | Stock Option (Right to Buy) | 572000 | $0.00 | 572,000.0000 | 0 | 9999.99% | 0.00% |
| June 24, 2024 | Aranda Richard | Chief Medical Officer | S | Common Stock | 1908 | $0.66 | 199,430.0000 | 0 | 0.95% | 0.00% |
| June 21, 2024 | Hasnain Faheem | President & CEO | P | Common Stock | 372000 | $0.67 | 5,528,366.0000 | 0 | 7.21% | 0.00% |
| June 17, 2024 | Smith Robert Paul JR | Chief Commercial Officer | P | Common Stock | 25000 | $0.60 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| June 18, 2024 | Giraudo Bryan | COO/CFO | P | Common Stock | 100000 | $0.59 | 480,010.0000 | 0 | 26.32% | 0.00% |
| June 6, 2024 | Daniel Thomas O | Director | A | Non-qualified stock option (Right to Buy) | 115000 | $0.00 | 115,000.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2024 | Cox Russell J. | Director | A | Non-qualified stock option (Right to Buy) | 115000 | $0.00 | 115,000.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2024 | Milligan Sandra | Director | A | Non-qualified stock option (Right to Buy) | 115000 | $0.00 | 115,000.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2024 | Quisel John D | Director | A | Non-qualified stock option (Right to Buy) | 115000 | $0.00 | 115,000.0000 | 0 | 9999.99% | 0.00% |
| March 27, 2024 | Christian Waage | EVP, Tech Ops and Admin | S | Common Stock | 6430 | $1.16 | 654,048.0000 | 0 | 0.97% | 0.00% |
| March 27, 2024 | Hasnain Faheem | President & CEO | S | Common Stock | 23172 | $1.16 | 5,156,366.0000 | 0 | 0.45% | 0.00% |
| March 27, 2024 | Giraudo Bryan | COO/CFO | S | Common Stock | 6430 | $1.16 | 472,747.0000 | 0 | 1.34% | 0.00% |
| March 18, 2024 | Peterson Caryn | EVP, Regulatory Affairs | S | Common Stock | 4018 | $1.33 | 49,833.0000 | 0 | 7.46% | 0.00% |
| March 18, 2024 | Aranda Richard | Chief Medical Officer | S | Common Stock | 4018 | $1.33 | 198,799.0000 | 0 | 1.98% | 0.00% |
| March 11, 2024 | Nathan Steven D | Director | A | Stock Option (Right to Buy) | 230000 | $0.00 | 230,000.0000 | 0 | 9999.99% | 0.00% |
| March 11, 2024 | Drynan Skye | Director | A | Stock Option (Right to Buy) | 230000 | $0.00 | 230,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | Peterson Caryn | EVP, Regulatory Affairs | A | Stock Option (Right to Buy) | 375000 | $0.00 | 375,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | Giraudo Bryan | COO/CFO | A | Stock Option (Right to Buy) | 543750 | $0.00 | 543,750.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | Hasnain Faheem | President & CEO | A | Stock Option (Right to Buy) | 1312500 | $0.00 | 1,312,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | Aranda Richard | Chief Medical Officer | A | Stock Option (Right to Buy) | 487500 | $0.00 | 487,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | Christian Waage | EVP, Tech Ops and Admin | A | Stock Option (Right to Buy) | 375000 | $0.00 | 375,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 4, 2023 | Smith Robert Paul JR | Chief Commercial Officer | A | Stock Option (Right to Buy) | 1500000 | $0.00 | 1,500,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 28, 2023 | Quisel John D | Director | A | Stock Option (Right to Buy) | 230000 | $0.00 | 230,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 20, 2023 | Giraudo Bryan | COO/CFO | A | Stock Option (Right to Buy) | 181250 | $0.00 | 181,250.0000 | 0 | 9999.99% | 0.00% |
| Nov. 20, 2023 | Peterson Caryn | EVP, Regulatory Affairs | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 20, 2023 | Aranda Richard | Chief Medical Officer | A | Stock Option (Right to Buy) | 162500 | $0.00 | 162,500.0000 | 0 | 9999.99% | 0.00% |
| Nov. 20, 2023 | Christian Waage | EVP, Tech Ops and Admin | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 20, 2023 | Hasnain Faheem | President & CEO | A | Stock Option (Right to Buy) | 437500 | $0.00 | 437,500.0000 | 0 | 9999.99% | 0.00% |
| Nov. 15, 2023 | Milligan Sandra | Director | P | Common Stock | 32000 | $0.79 | 32,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 13, 2023 | Giraudo Bryan | COO/CFO | P | Common Stock | 200000 | $0.56 | 479,177.0000 | 0 | 71.64% | 0.00% |
| July 24, 2023 | Hasnain Faheem | President & CEO | A | Common Stock Purchase Warrants | 135044 | $0.13 | 135,044.0000 | 0 | 9999.99% | 0.00% |
| July 24, 2023 | Hasnain Faheem | President & CEO | A | Common Stock | 540176 | $1.82 | 5,179,538.0000 | 0 | 11.64% | 0.00% |
| July 24, 2023 | Giraudo Bryan | COO/CFO | A | Common Stock | 13505 | $0.13 | 13,505.0000 | 0 | 9999.99% | 0.00% |
| July 24, 2023 | Giraudo Bryan | COO/CFO | A | Common Stock | 54020 | $1.82 | 250,389.0000 | 0 | 27.51% | 0.00% |
| July 24, 2023 | Christian Waage | EVP, Tech Ops and Admin | A | Common Stock | 13504 | $1.82 | 650,592.0000 | 0 | 2.12% | 0.00% |
| July 24, 2023 | Christian Waage | EVP, Tech Ops and Admin | A | Common Stock Purchase Warrants | 3376 | $0.13 | 3,376.0000 | 0 | 9999.99% | 0.00% |
| June 22, 2023 | Aranda Richard | Chief Medical Officer | S | Common Stock | 1814 | $1.29 | 200,113.0000 | 0 | 0.90% | 0.00% |
| June 8, 2023 | Milligan Sandra | Director | A | Stock Option (Right to Buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | Cox Russell J. | Director | A | Stock Option (Right to Buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | GALA RENEE D | Director | A | Stock Option (Right to Buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | Burow Kristina | Director | A | Stock Option (Right to Buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| June 8, 2023 | Daniel Thomas O | Director | A | Stock Option (Right to Buy) | 35000 | $0.00 | 35,000.0000 | 0 | 9999.99% | 0.00% |
| May 5, 2023 | Hasnain Faheem | President & CEO | A | Stock Option (Right to Buy) | 750000 | $0.00 | 750,000.0000 | 0 | 9999.99% | 0.00% |
| May 5, 2023 | Peterson Caryn | EVP, Regulatory Affairs | D | Stock Option (Right to Buy) | 48500 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 5, 2023 | Peterson Caryn | EVP, Regulatory Affairs | D | Stock Option (Right to Buy) | 13750 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 5, 2023 | Peterson Caryn | EVP, Regulatory Affairs | D | Stock Option (Right to Buy) | 34175 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 5, 2023 | Peterson Caryn | EVP, Regulatory Affairs | D | Stock Option (Right to Buy) | 28250 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 5, 2023 | Peterson Caryn | EVP, Regulatory Affairs | D | Stock Option (Right to Buy) | 31750 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 5, 2023 | Peterson Caryn | EVP, Regulatory Affairs | D | Stock Option (Right to Buy) | 190000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 5, 2023 | Peterson Caryn | EVP, Regulatory Affairs | A | Stock Option (Right to Buy) | 32334 | $0.00 | 32,334.0000 | 0 | 9999.99% | 0.00% |
| May 5, 2023 | Peterson Caryn | EVP, Regulatory Affairs | A | Stock Option (Right to Buy) | 9167 | $0.00 | 9,167.0000 | 0 | 9999.99% | 0.00% |
| May 5, 2023 | Peterson Caryn | EVP, Regulatory Affairs | A | Stock Option (Right to Buy) | 22784 | $0.00 | 22,784.0000 | 0 | 9999.99% | 0.00% |
| May 5, 2023 | Peterson Caryn | EVP, Regulatory Affairs | A | Stock Option (Right to Buy) | 18834 | $0.00 | 18,834.0000 | 0 | 9999.99% | 0.00% |
| May 5, 2023 | Peterson Caryn | EVP, Regulatory Affairs | A | Stock Option (Right to Buy) | 21167 | $0.00 | 21,167.0000 | 0 | 9999.99% | 0.00% |
| May 5, 2023 | Peterson Caryn | EVP, Regulatory Affairs | A | Stock Option (Right to Buy) | 126667 | $0.00 | 126,667.0000 | 0 | 9999.99% | 0.00% |
| May 5, 2023 | Aranda Richard | Chief Medical Officer | D | Stock Option (Right to Buy) | 45000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 5, 2023 | Aranda Richard | Chief Medical Officer | D | Stock Option (Right to Buy) | 13750 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 5, 2023 | Aranda Richard | Chief Medical Officer | D | Stock Option (Right to Buy) | 34175 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 5, 2023 | Aranda Richard | Chief Medical Officer | D | Stock Option (Right to Buy) | 60000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 5, 2023 | Aranda Richard | Chief Medical Officer | D | Stock Option (Right to Buy) | 30000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 5, 2023 | Aranda Richard | Chief Medical Officer | D | Stock Option (Right to Buy) | 190000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 5, 2023 | Aranda Richard | Chief Medical Officer | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| May 5, 2023 | Aranda Richard | Chief Medical Officer | A | Stock Option (Right to Buy) | 9167 | $0.00 | 9,167.0000 | 0 | 9999.99% | 0.00% |
| May 5, 2023 | Aranda Richard | Chief Medical Officer | A | Stock Option (Right to Buy) | 22784 | $0.00 | 22,784.0000 | 0 | 9999.99% | 0.00% |
| May 5, 2023 | Aranda Richard | Chief Medical Officer | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| May 5, 2023 | Aranda Richard | Chief Medical Officer | A | Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |
| May 5, 2023 | Aranda Richard | Chief Medical Officer | A | Stock Option (Right to Buy) | 126667 | $0.00 | 126,667.0000 | 0 | 9999.99% | 0.00% |
| May 5, 2023 | Christian Waage | EVP, Tech Ops and Admin | D | Stock Option (Right to Buy) | 105000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 5, 2023 | Christian Waage | EVP, Tech Ops and Admin | D | Stock Option (Right to Buy) | 71500 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 5, 2023 | Christian Waage | EVP, Tech Ops and Admin | D | Stock Option (Right to Buy) | 90000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 5, 2023 | Christian Waage | EVP, Tech Ops and Admin | D | Stock Option (Right to Buy) | 190000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 5, 2023 | Christian Waage | EVP, Tech Ops and Admin | A | Stock Option (Right to Buy) | 70000 | $0.00 | 70,000.0000 | 0 | 9999.99% | 0.00% |
| May 5, 2023 | Christian Waage | EVP, Tech Ops and Admin | A | Stock Option (Right to Buy) | 47667 | $0.00 | 47,667.0000 | 0 | 9999.99% | 0.00% |
| May 5, 2023 | Christian Waage | EVP, Tech Ops and Admin | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |
| May 5, 2023 | Christian Waage | EVP, Tech Ops and Admin | A | Stock Option (Right to Buy) | 126667 | $0.00 | 126,667.0000 | 0 | 9999.99% | 0.00% |
| May 5, 2023 | Giraudo Bryan | COO/CFO | D | Stock Option (Right to Buy) | 145000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 5, 2023 | Giraudo Bryan | COO/CFO | D | Stock Option (Right to Buy) | 71500 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 5, 2023 | Giraudo Bryan | COO/CFO | D | Stock Option (Right to Buy) | 90000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 5, 2023 | Giraudo Bryan | COO/CFO | D | Stock Option (Right to Buy) | 150000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 5, 2023 | Giraudo Bryan | COO/CFO | D | Stock Option (Right to Buy) | 265000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 5, 2023 | Giraudo Bryan | COO/CFO | A | Stock Option (Right to Buy) | 96667 | $0.00 | 96,667.0000 | 0 | 9999.99% | 0.00% |
| May 5, 2023 | Giraudo Bryan | COO/CFO | A | Stock Option (Right to Buy) | 47667 | $0.00 | 47,667.0000 | 0 | 9999.99% | 0.00% |
| May 5, 2023 | Giraudo Bryan | COO/CFO | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |
| May 5, 2023 | Giraudo Bryan | COO/CFO | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| May 5, 2023 | Giraudo Bryan | COO/CFO | A | Stock Option (Right to Buy) | 176667 | $0.00 | 176,667.0000 | 0 | 9999.99% | 0.00% |
| April 4, 2023 | Giraudo Bryan | COO/CFO | P | Common Stock | 55000 | $1.02 | 225,157.0000 | 0 | 32.32% | 0.00% |
| March 20, 2023 | Giraudo Bryan | COO/CFO | A | Stock Option (Right to Buy) | 211500 | $0.00 | 211,500.0000 | 0 | 9999.99% | 0.00% |
| March 20, 2023 | Aranda Richard | Chief Medical Officer | A | Stock Option (Right to Buy) | 157500 | $0.00 | 157,500.0000 | 0 | 9999.99% | 0.00% |
| March 20, 2023 | Peterson Caryn | EVP, Regulatory Affairs | A | Stock Option (Right to Buy) | 157500 | $0.00 | 157,500.0000 | 0 | 9999.99% | 0.00% |
| March 20, 2023 | Carter Laura | Chief Scientific Officer | A | Stock Option (Right to Buy) | 157500 | $0.00 | 157,500.0000 | 0 | 9999.99% | 0.00% |
| March 20, 2023 | Hasnain Faheem | President & CEO | A | Stock Option (Right to Buy) | 544500 | $0.00 | 544,500.0000 | 0 | 9999.99% | 0.00% |
| March 22, 2023 | Hasnain Faheem | President & CEO | P | Common Stock | 440500 | $1.14 | 4,639,362.0000 | 0 | 10.49% | 0.00% |
| March 21, 2023 | Hasnain Faheem | President & CEO | P | Common Stock | 269389 | $1.20 | 4,198,862.0000 | 0 | 6.86% | 0.00% |
| March 20, 2023 | Hasnain Faheem | President & CEO | P | Common Stock | 168683 | $1.03 | 3,929,473.0000 | 0 | 4.49% | 0.00% |
| March 20, 2023 | Giraudo Bryan | COO/CFO | P | Common Stock | 50000 | $0.97 | 170,157.0000 | 0 | 41.61% | 0.00% |
| March 20, 2023 | Christian Waage | EVP, Tech Ops and Admin | A | Stock Option (Right to Buy) | 157500 | $0.00 | 157,500.0000 | 0 | 9999.99% | 0.00% |
| March 20, 2023 | Christian Waage | EVP, Tech Ops and Admin | P | Common Stock | 18500 | $1.20 | 637,088.0000 | 0 | 2.99% | 0.00% |
| March 16, 2023 | Peterson Caryn | EVP, Regulatory Affairs | S | Common Stock | 7564 | $1.10 | 53,851.0000 | 0 | 12.32% | 0.00% |
| March 16, 2023 | Carter Laura | Chief Scientific Officer | S | Common Stock | 6029 | $1.10 | 76,263.0000 | 0 | 7.33% | 0.00% |
| March 16, 2023 | Aranda Richard | Chief Medical Officer | S | Common Stock | 7563 | $1.10 | 201,927.0000 | 0 | 3.61% | 0.00% |